COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know: https://www.cancer.gov/coronavirus

Guidance for cancer researchers: https://www.cancer.gov/coronavirus-researchers

Get the latest public health information from CDC: https://www.coronavirus.gov

Get the latest research information from NIH: https://www.nih.gov/coronavirus

Characterization of Nanoparticles Intended for Drug Delivery

The NCL has recently published a follow-on book to its Characterization of nanoparticles intended for drug delivery. This second edition book, now available for download or purchase, offers new and updated protocols for sterility and endotoxin testing, surface coating quantitation, ICP-MS of biological matrices, in vitro hematotoxicity and immunotoxicity, as well as in vitro methods for evaluating nanoparticle drug release in biological matrix. 

Characterization of nanoparticles intended for drug delivery, Scott E. McNeil, Editor. Methods in Molecular Biology. Vol. 1628, 2018, Humana Press, New York, NY.  ISBN: 978-1-4939-7350-7

If you have any questions on any of these protocols, please let us know.